SPC
ARNA

Sigma Planning Corp’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Sigma Planning Corp’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,140
Closed -$40K – 796
2014
Q4 		$40K Buy
+1,140
New +$46.3K 0.01% 703

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sigma Planning Corp's ARNA Position: Q1 2015 in Review

Sigma Planning Corp sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2015, closing a stake of 1,140 shares — an estimated $40K sold.

Sigma Planning Corp first reported a position in ARNA in Q4 2014 and held it in 1 quarter. The position peaked at $40K in Q4 2014. 122 funds tracked by Wall St. Rank hold ARNA as of Q1 2015.

  • Sigma Planning Corp reported no remaining Arena Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Sigma Planning Corp sold 1,140 Arena Pharmaceuticals Inc shares in Q1 2015, an estimated $40K.
  • Sigma Planning Corp first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 1 quarter.
  • Sigma Planning Corp's Arena Pharmaceuticals Inc position peaked at $40K in Q4 2014.
  • 122 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2015.

Based on Sigma Planning Corp's 13F filing for Q1 2015, filed 23 Apr 2015.